EQT Launches $371 Million Tender Offer to Privatize Japanese IT Firm MAMEZO
EQT, through its BPEA Mid-Market Growth Partnership fund, has initiated a $371 million tender offer to take full ownership of […]
Wahl Professional Crowns Cristian Botello as U.S. Barber Battle Champion, Eyes Global Glory in Chicago
“Cristian Botello, a seasoned barber from Temecula, California, emerges victorious in the U.S. Barber Battle hosted by Wahl Professional, showcasing
ZTO Express Unveils 2026 Roadmap at National Network Conference Following Stellar 2025 Performance
“ZTO Express achieved a record 38.52 billion parcels in 2025, marking a 13.3% year-over-year growth and securing its position as
Analysts Turn More Bullish on Guardant Health, Inc. (GH) as 2026 Growth Catalysts Build
Analysts are increasingly optimistic about Guardant Health’s prospects, citing robust revenue momentum, innovative product launches, and strategic partnerships as key
ImmunityBio’s Allogeneic CD19 CAR-NK Therapy Achieves Sustained Complete Remission in Waldenstrom Lymphoma
ImmunityBio’s off-the-shelf CD19-targeted CAR-NK cell therapy, combined with rituximab, has demonstrated durable complete responses lasting over 15 months in patients
Ageing, Smoking, Oral Bacteria, and Genetic Mutations Linked to Higher Stomach Cancer Risk
“Recent research highlights how ageing processes, smoking habits, specific oral bacteria, and genetic mutations interact to significantly increase stomach cancer
Wall Street Analysts Predict 9% Returns for S&P 500 in 2026. Here’s How to Build Wealth (Even If Markets Don’t Stay Hot)
“Wall Street experts forecast 9% returns for the S&P 500 in 2026, driven by easing inflation and steady corporate earnings,
Tesla’s Full Self-Driving Goes Subscription-Only: A Shift in Autonomous Revenue Strategy
“Tesla is discontinuing one-time purchases of its Full Self-Driving (FSD) software after February 14, 2026, opting instead for a $99
As Stablecoins Surge, Governments Worldwide Ramp Up Regulatory Responses
“Stablecoins have exploded in transaction volume to $33 trillion in the past year, prompting a wave of regulatory actions globally.
Investors Worried About Palantir’s Valuation Last Year. Is it a Buy Now in 2026?
“Palantir’s stock surged dramatically in recent years amid AI-driven growth, but high valuations sparked investor concerns in 2025. Entering 2026,